Skip to Main Content

Paper Details

Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
Sci Rep
12
2021
Author NameAffiliation
Andr??s KristonBiological Research Centre
Andr??s KristonSingle-Cell Technologies Ltd
Peter HorvathSingle-Cell Technologies Ltd
Peter HorvathInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Peter HorvathBiological Research Centre
  • 1 - 5

Datasets

Release 1.2